In a 2008 Clemson World story, Schanen '84 revealed that she began her studies at Clemson as a pre-veterinary student but changed her major to medicine, following in her physician father's footsteps. She also discovered her love for research and was encouraged by Clemson faculty to follow her interest.
Schanen has never turned back. "My research experiences as an undergraduate at Clemson shaped my career," she says. "I learned that there were no questions too tough to tackle. It just takes patience and perseverance."
Today, Schanen serves in a number of important positions. She is adjunct associate professor at the University of Delaware, and head of human genetics research and director of the Human Genetics Research Lab at the Center for Applied Clinical Genomics at Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del.
Schanen is a leader in research focused on understanding the molecular and cellular basis of human neurogenetic disorders, including Rett syndrome, a form of autism caused by an abnormality of chromosome 15 and an inherited form of stroke.
B.A. University of Tennessee at Chattanooga
Ph.D. Clemson University
Postdoctoral University of Georgia
During his 21-year association with the Walter Reed Army Institute of Research, Dennis E. Kyle ’84 led key efforts with the U.S. Army’s Drug and Vaccine Development Programs, moving into the post of deputy director of the Division of Experimental Therapeutics. He also served as the chief, Department of Immunology and Parasitology at the Armed Forces Research Institute of Medical Sciences in Bangkok, Thailand, and was a senior scientist in the malaria drug program at the Australian Army Malaria Institute. Kyle has more than 140 publications in the peerreviewed scientific literature, serves on peer review panels for the National Institutes of Health and the World Health Organization (WHO), and chaired the Genomics and Discovery Research Steering Committee and the Compound Evaluation Network for WHO.
Kyle’s research interests include the discovery and development of new antiparasitic drugs and elucidation of mechanisms of antimalarial drug resistance. Today, Kyle is Distinguished University Health Professor at the University of South Florida, Tampa, working with students in basic and translational approaches to drug discovery and development as well as chemical biology of antiparasitic drugs and elucidation of drug resistance mechanisms.